Systematic review of 33 studies in Lynch syndrome carriers, mostly retrospective family studies, meta-analysed by gene: colorectal cancer risk at 40 was <2% for MSH6 and PMS2 vs >4% for MLH1 and MSH2; endometrial cancer risk at 50 ranged from 3.0% (PMS2) to 8.7% (MSH2).
Meta-analysisn = 33 studies
Campoy et al. Cancer risks in Lynch syndrome carriers: a systematic review and meta-analysis